North America Cell and Gene Therapy Market to 2031 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Cell and Gene Therapy Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Cell and Gene Therapy Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increase in Number of Approval of Cell and Gene Therapies
5.1.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing

5.2 Market Opportunities

5.2.1 Strategic Initiatives by Companies

5.3 Future Trends

5.3.1 Automation of Cell and Gene Therapy Manufacturing Services

5.4 Impact of Drivers and Restraints

6. North America Cell and Gene Therapy Market Regional Analysis

6.1 North America Cell and Gene Therapy Market Overview

6.2 North America Cell and Gene Therapy Market Revenue 2021-2031 (US$ Million)

6.3 North America Cell and Gene Therapy Market Forecast Analysis

7. North America Cell and Gene Therapy Market Analysis – by Type

7.1 Cell Therapy

7.1.1 Overview
7.1.2 Cell Therapy: North America Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Gene Therapy

7.2.1 Overview
7.2.2 Gene Therapy: North America Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Cell and Gene Therapy Market Analysis – by Services

8.1 Process Development

8.1.1 Overview
8.1.2 Process Development: North America Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8.2 cGMP Manufacturing

8.2.1 Overview
8.2.2 cGMP Manufacturing: North America Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8.3 Regulatory Services

8.3.1 Overview
8.3.2 Regulatory Services: North America Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8.4 Bioassay Services

8.4.1 Overview
8.4.2 Bioassay Services: North America Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

9. North America Cell and Gene Therapy Market Analysis – by Scale

9.1 Pre Commercial/R

9.1.1 Overview
9.1.2 Bioassay Services: North America Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

9.2 D Manufacturing

9.2.1 Overview
9.2.2 Bioassay Services: North America Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

9.3 Commercial Scale Manufacturing

9.3.1 Overview
9.3.2 Bioassay Services: North America Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

10. North America Cell and Gene Therapy Market – North America Analysis

10.1 North America

10.1.1 North America Cell and Gene Therapy Market Breakdown, by Key Country, 2025 and 2031 (%)
10.1.1.1 North America Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.1.1 US: North America Cell and Gene Therapy Market Breakdown, by Type
10.1.1.1.2 US: North America Cell and Gene Therapy Market Breakdown, by Services
10.1.1.1.3 US: North America Cell and Gene Therapy Market Breakdown, by Scale

10.1.1.2 Canada: North America Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.2.1 Canada: North America Cell and Gene Therapy Market Breakdown, by Type
10.1.1.2.2 Canada: North America Cell and Gene Therapy Market Breakdown, by Services
10.1.1.2.3 Canada: North America Cell and Gene Therapy Market Breakdown, by Scale

10.1.1.3 Mexico: North America Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.3.1 Mexico: North America Cell and Gene Therapy Market Breakdown, by Type
10.1.1.3.2 Mexico: North America Cell and Gene Therapy Market Breakdown, by Services
10.1.1.3.3 Mexico: North America Cell and Gene Therapy Market Breakdown, by Scale

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Cell and Gene Therapy Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Catalent Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Charles River Laboratories International Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 F. Hoffmann-La Roche Ltd

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 FUJIFILM Holdings Corp

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Lonza Group AG

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Lotte Corp

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Merck KGaA

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Takara Bio Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Thermo Fisher Scientific Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 WuXi AppTec Co Ltd

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights